Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials

R Peto; C Davies; J Godwin; R Gray; H C Pan; M Clarke; D Cutter; S Darby; P McGale; C Taylor; Y C Wang; J Bergh; A Di Leo; K Albain; S Swain; M Piccart; K Pritchard; Early Breast Cancer Trialists' Collaborative Group (EBCTCG)

doi:10.1016/S0140-6736(11)61625-5

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials

R Peto, C Davies, J Godwin, R Gray, H C Pan, M Clarke, D Cutter, S Darby, P McGale, C Taylor, Y C Wang, J Bergh, A Di Leo, K Albain, S Swain, M Piccart, K Pritchard, Early Breast Cancer Trialists' Collaborative Group (EBCTCG)

Research output: Contribution to journal › Article › peer-review

Abstract

Moderate differences in efficacy between adjuvant chemotherapy regimens for breast cancer are plausible, and could affect treatment choices. We sought any such differences.

Original language	English
Pages (from-to)	432-44
Number of pages	13
Journal	The Lancet
Volume	379
Issue number	9814
DOIs	https://doi.org/10.1016/S0140-6736(11)61625-5
Publication status	Published - 2012

Access to Document

10.1016/S0140-6736(11)61625-5

Comparisons between different polychemotherapy regimens for early breast cancer
Available under Open Access.
Final published version, 572 KB

http://www.sciencedirect.com/science/article/pii/S0140673611616255

Cite this

Peto, R., Davies, C., Godwin, J., Gray, R., Pan, H. C., Clarke, M., Cutter, D., Darby, S., McGale, P., Taylor, C., Wang, Y. C., Bergh, J., Di Leo, A., Albain, K., Swain, S., Piccart, M., Pritchard, K., & Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2012). Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. The Lancet, 379(9814), 432-44. https://doi.org/10.1016/S0140-6736(11)61625-5

@article{f3ecc288def147c6aeadd705aae852ed,

title = "Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials",

abstract = "Moderate differences in efficacy between adjuvant chemotherapy regimens for breast cancer are plausible, and could affect treatment choices. We sought any such differences.",

author = "R Peto and C Davies and J Godwin and R Gray and Pan, \{H C\} and M Clarke and D Cutter and S Darby and P McGale and C Taylor and Wang, \{Y C\} and J Bergh and \{Di Leo\}, A and K Albain and S Swain and M Piccart and K Pritchard and \{Early Breast Cancer Trialists' Collaborative Group (EBCTCG)\} and David Cameron",

year = "2012",

doi = "10.1016/S0140-6736(11)61625-5",

language = "English",

volume = "379",

pages = "432--44",

journal = "The Lancet",

issn = "1474-547X",

publisher = "Elsevier",

number = "9814",

}

Peto, R, Davies, C, Godwin, J, Gray, R, Pan, HC, Clarke, M, Cutter, D, Darby, S, McGale, P, Taylor, C, Wang, YC, Bergh, J, Di Leo, A, Albain, K, Swain, S, Piccart, M, Pritchard, K & Early Breast Cancer Trialists' Collaborative Group (EBCTCG) 2012, 'Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials', The Lancet, vol. 379, no. 9814, pp. 432-44. https://doi.org/10.1016/S0140-6736(11)61625-5

TY - JOUR

T1 - Comparisons between different polychemotherapy regimens for early breast cancer

T2 - meta-analyses of long-term outcome among 100,000 women in 123 randomised trials

AU - Peto, R

AU - Davies, C

AU - Godwin, J

AU - Gray, R

AU - Pan, H C

AU - Clarke, M

AU - Cutter, D

AU - Darby, S

AU - McGale, P

AU - Taylor, C

AU - Wang, Y C

AU - Bergh, J

AU - Di Leo, A

AU - Albain, K

AU - Swain, S

AU - Piccart, M

AU - Pritchard, K

AU - Early Breast Cancer Trialists' Collaborative Group (EBCTCG)

AU - Cameron, David

PY - 2012

Y1 - 2012

N2 - Moderate differences in efficacy between adjuvant chemotherapy regimens for breast cancer are plausible, and could affect treatment choices. We sought any such differences.

AB - Moderate differences in efficacy between adjuvant chemotherapy regimens for breast cancer are plausible, and could affect treatment choices. We sought any such differences.

U2 - 10.1016/S0140-6736(11)61625-5

DO - 10.1016/S0140-6736(11)61625-5

M3 - Article

C2 - 22152853

SN - 1474-547X

VL - 379

SP - 432

EP - 444

JO - The Lancet

JF - The Lancet

IS - 9814

ER -

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials

Abstract

Access to Document

Fingerprint

Cite this